Details for New Drug Application (NDA): 009818
✉ Email this page to a colleague
NDA 009818 describes KEMADRIN, which is a drug marketed by Monarch Pharms and is included in one NDA. Additional details are available on the KEMADRIN profile page.
The generic ingredient in KEMADRIN is procyclidine hydrochloride. There is one drug master file entry for this compound. Additional details are available on the procyclidine hydrochloride profile page.
The generic ingredient in KEMADRIN is procyclidine hydrochloride. There is one drug master file entry for this compound. Additional details are available on the procyclidine hydrochloride profile page.
Summary for 009818
| Tradename: | KEMADRIN |
| Applicant: | Monarch Pharms |
| Ingredient: | procyclidine hydrochloride |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 009818
Profile for product number 003
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 5MG | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Profile for product number 005
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 2MG | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
